These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 15505099)
21. Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem. Gonzalez ER; Ornato JP; Lawson CL Pharmacotherapy; 1994; 14(4):446-51. PubMed ID: 7937281 [TBL] [Abstract][Full Text] [Related]
22. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation. Dan GA; Gonţa A Rom J Intern Med; 1997; 35(1-4):19-27. PubMed ID: 9562649 [TBL] [Abstract][Full Text] [Related]
23. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model. Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of wild-type Galpha(i)-2 suppresses beta-adrenergic signaling in cardiac myocytes. Rau T; Nose M; Remmers U; Weil J; Weissmüller A; Davia K; Harding S; Peppel K; Koch WJ; Eschenhagen T FASEB J; 2003 Mar; 17(3):523-5. PubMed ID: 12631586 [TBL] [Abstract][Full Text] [Related]
26. Who, when and how to rate control for atrial fibrillation. Rienstra M; Van Gelder IC Curr Opin Cardiol; 2008 Jan; 23(1):23-7. PubMed ID: 18281823 [TBL] [Abstract][Full Text] [Related]
27. Management of atrial fibrillation in heart failure in the elderly. Abi Nasr I; Mansencal N; Dubourg O Int J Cardiol; 2008 Apr; 125(2):178-82. PubMed ID: 18029038 [TBL] [Abstract][Full Text] [Related]
28. Effects of diltiazem and esmolol on cycle length and spontaneous conversion of atrial fibrillation. Sticherling C; Tada H; Hsu W; Bares AC; Oral H; Pelosi F; Knight BP; Strickberger SA; Morady F J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):81-8. PubMed ID: 12075396 [TBL] [Abstract][Full Text] [Related]
29. Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study. Trappe K; Thomas D; Bikou O; Kelemen K; Lugenbiel P; Voss F; Becker R; Katus HA; Bauer A Eur Heart J; 2013 Jan; 34(2):147-57. PubMed ID: 21785105 [TBL] [Abstract][Full Text] [Related]
30. Beta-blockers versus digoxin to control ventricular rate during atrial fibrillation. Veloso HH; de Paola AA J Am Coll Cardiol; 2005 Jun; 45(11):1905-6; author reply 1906-7. PubMed ID: 15936626 [No Abstract] [Full Text] [Related]
34. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Redfield MM; Kay GN; Jenkins LS; Mianulli M; Jensen DN; Ellenbogen KA Mayo Clin Proc; 2000 Aug; 75(8):790-5. PubMed ID: 10943231 [TBL] [Abstract][Full Text] [Related]
36. Short-term effects of right-left heart sequential cardiac resynchronization in patients with heart failure, chronic atrial fibrillation, and atrioventricular nodal block. Hay I; Melenovsky V; Fetics BJ; Judge DP; Kramer A; Spinelli J; Reister C; Kass DA; Berger RD Circulation; 2004 Nov; 110(22):3404-10. PubMed ID: 15557370 [TBL] [Abstract][Full Text] [Related]
37. Assessment of left ventricular pacing in patients with severe cardiac failure after atrioventricular node ablation and right ventricular pacing for permanent atrial fibrillation. Blanc JJ; Etienne Y; Gilard M Europace; 1999 Jan; 1(1):47-8. PubMed ID: 11220540 [No Abstract] [Full Text] [Related]
38. Rate control in atrial fibrillation: looking beyond the average heart rate. Ahmad K; Dorian P Curr Opin Cardiol; 2006 Mar; 21(2):88-93. PubMed ID: 16470141 [TBL] [Abstract][Full Text] [Related]
39. From catheters to vectors: the dawn of molecular electrophysiology. Priori SG; Napolitano C Nat Med; 2000 Dec; 6(12):1316-8. PubMed ID: 11100108 [No Abstract] [Full Text] [Related]
40. Outcomes after atrioventricular node ablation and biventricular pacing in patients with refractory atrial fibrillation and heart failure: a comparison between non-ischaemic and ischaemic cardiomyopathy. Sohinki D; Ho J; Srinivasan N; Collins LJ; Obel OA Europace; 2014 Jun; 16(6):880-6. PubMed ID: 24525552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]